Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kathleen Ruehle
Rapid Relapse of Large B‐Cell Lymphoma After CD19 Directed CAR‐T‐Cell Therapy Due to CD‐19 Antigen Loss
American Journal of Hematology
Hematology
Refractory Post‐Allogeneic Stem Cell Transplant Pure Red Cell Aplasia in Remission After Treatment With Daratumumab
American Journal of Hematology
Hematology
Related publications
Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cd19-Directed Car T Cell Therapy (Ctl019) for Relapsed/Refractory Diffuse Large B-Cell and Follicular Lymphomas: Four Year Outcomes
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cytokine Release Syndrome and Neurotoxicity After CD19 Chimeric Antigen Receptor-Modified (CAR-) T Cell Therapy
British Journal of Haematology
Hematology
Safety of Allogeneic Hematopoietic Cell Transplant in Adults After Cd19 Targeted Chimeric Antigen Receptor-Modified T-Cell (Car-T) Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Outcomes of Patients With Large B‐Cell Lymphomas and Progressive Disease Following CD19‐Specific CAR T‐Cell Therapy
American Journal of Hematology
Hematology
MSKCC Early Experience Using Radiotherapy as a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma Before Cd19 Car T Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
High Rate of Durable Complete Remission in Follicular Lymphoma After Cd19 Car-T Cell Immunotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Toxicities of CD19 CAR-T Cell Immunotherapy
American Journal of Hematology
Hematology
Establishing a Model System for Evaluating CAR T Cell Therapy Using Dogs With Spontaneous Diffuse Large B Cell Lymphoma
OncoImmunology
Oncology
Allergy
Immunology